Aisling Capital Management’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $212K | Hold |
88,607
| – | – | 0.06% | 13 |
|
|
2025
Q1 | $381K | Hold |
88,607
| – | – | 0.13% | 13 |
|
|
2024
Q4 | $762K | Sell |
88,607
-1
| -0% | -$9 | 0.27% | 14 |
|
|
2024
Q3 | $1.51M | Hold |
88,608
| – | – | 0.58% | 13 |
|
|
2024
Q2 | $1.34M | Hold |
88,608
| – | – | 0.58% | 13 |
|
|
2024
Q1 | $1.47M | Hold |
88,608
| – | – | 0.5% | 11 |
|
|
2023
Q4 | $1.42M | Hold |
88,608
| – | – | 0.42% | 12 |
|
|
2023
Q3 | $6.74M | Hold |
88,608
| – | – | 2.78% | 7 |
|
|
2023
Q2 | $5.81M | Hold |
88,608
| – | – | 2.85% | 6 |
|
|
2023
Q1 | $5.3M | Hold |
88,608
| – | – | 2.55% | 7 |
|
|
2022
Q4 | $2.06M | Hold |
88,608
| – | – | 1.36% | 10 |
|
|
2022
Q3 | $2.97M | Hold |
88,608
| – | – | 1.97% | 10 |
|
|
2022
Q2 | $2.35M | Hold |
88,608
| – | – | 1.68% | 11 |
|
|
2022
Q1 | $2.61M | Hold |
88,608
| – | – | 1.41% | 13 |
|
|
2021
Q4 | $7.58M | Hold |
88,608
| – | – | 2.67% | 11 |
|
|
2021
Q3 | $6.6M | Hold |
88,608
| – | – | 1.32% | 14 |
|
|
2021
Q2 | $8.27M | Buy |
+88,608
| New | +$8.27M | 1.32% | 16 |
|